| SCLX Stock Acquisition JV LLC |
10%+ Owner |
$52.9M |
|
|
Sep 22, 2023 |
| Sorrento Therapeutics, Inc. |
10%+ Owner |
$1.69M |
|
|
Sep 21, 2023 |
| Henry Ji |
Executive Chairperson, Director |
$583K |
+$62K |
+11.9% |
Oct 31, 2024 |
| Jaisim Shah |
Chief Executive Officer and President, Director |
$262K |
+$183K |
+232% |
Oct 29, 2024 |
| Jay Chun |
Director |
$107K |
+$56.4K |
+112% |
Oct 18, 2024 |
| Yue Alexander Wu |
Director |
$23.7K |
+$19K |
+400% |
Oct 17, 2024 |
| Stephen Hoi Ma |
Chief Financial Officer |
$22.2K |
+$18.9K |
+590% |
Oct 16, 2024 |
| Dorman Followwill |
Director |
$2.28K |
+$990 |
+76.9% |
Oct 18, 2024 |
| David Lemus |
Director |
$1.8K |
+$1.8K |
|
Oct 17, 2024 |
| Annu Navani |
Director |
|
|
|
Aug 16, 2024 |
| Laura Hamill |
Director |
|
|
|
Jan 17, 2023 |
| Tommy G. Thompson |
Director |
|
|
|
Jan 17, 2023 |
| Elizabeth Czerepak |
Executive Vice President, Chief Business Officer and Chief Financial Officer |
|
|
|
Jan 17, 2023 |
| Tien-Li Lee |
Director |
|
|
|
Jan 17, 2023 |
| Steve Myint |
Director, Effective November 10, 2022, Steve Myint is no longer a Director of Vickers Vantage Corp. I |
|
|
|
Nov 10, 2022 |
| Suneel G. Kaji |
Director, Effective November 10, 2022, Suneel G. Kaji is no longer a Director of Vickers Vantage Corp. I |
|
|
|
Nov 10, 2022 |
| Pei Wei Woo |
Director, Effective November 10, 2022, Pei Wei Woo is no longer a Director of Vickers Vantage Corp. I |
|
|
|
Nov 10, 2022 |
| Vickers Venture Fund VI Pte Ltd |
Other*, 10%+ Owner |
|
|
|
Nov 10, 2022 |